Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Microbix to Build Flu Vaccine Plant in Hunan

publication date: Jun 24, 2008

Microbix Biosystems Inc. will establish a joint venture to build a very large influenza vaccine facility in China with financial help from the Hunan provincial government. The $197 million facility will receive a $99 million incentive from the provincial government of Hunan, which will also purchase the first 100 million doses of vaccine. Microbix plans to raise the rest of the money from its licensing partners. More details...

Stock Symbol: (Toronto: MBX)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital